body aches and tirzepatide Side Effects Muscle Pain tirzepatide side effects soreness Mounjaro

Journal of Endocrinology & Metabolism

Of note, current research investigates nanomedicines to increase -tocopheryl succinate bioavailability before exploring putative benefits in clinical settings (118)

Novo Nordisk says the US FDA has approved a once daily pill version of Wegovy, described as the first approved pill of its kind The company said trials showed average weight loss of 16.6%, with about a third of roughly 1,300 participants losing 20% or more Novo Nordisk expects a US launch in early January 2026, with investors pushing shares up sharply after the announcement amid strong competition in the weight loss market US regulators have approved an oral version of Wegovy for chronic weight management, giving Novo Nordisk the first daily pill in this drug class cleared for obesity treatment, according to the company and US media reports

If you have not lost at least 5% of your starting body weight after 6 months , your doctor will probably advise you to stop using Mounjaro, as its unlikely to be an effective weight loss medication for you